Live

FierceBiotechIn next-gen IO race in NSCLC, BioNTech/BMS and Pfizer are divided on overall survival approach CellDecoding the spatiotemporal development of human meninges CellFronto-insular circuit mechanisms of accelerated intermittent theta burst stimulation CellPhysiological brain clearance architecture revealed by neuronal protein tracing FierceBiotechASCO: Gilead touts ADC ovarian cancer data as proof Tubulis buyout was ‘a good deal’Endpoints NewsCan AI do scientific research?; The 'magic bullet' search has faded in immunotherapy; and more IlluminaIllumina Ducks DNA Sequence Rival's Antitrust Suit, For Now - Law360 BioPharma DiveAt ASCO, Merck makes case for a ‘cornerstone’ cancer drug BioPharma DiveBristol Myers unveils data for one of its next-gen blood cancer drugs Clinical OMICsTeclistamab Outperforms Standard Therapy in Relapsed Multiple Myeloma Clinical OMICsAI Chatbots Do Not Consistently Deliver Accurate Health Responses FierceBiotechLegend scientific founder returns to ASCO with new ambition for high-yield, non-gene-editing CAR-T platform

PLoS Biology 29. Mai 2026

Do you want to live forever? Lessons learned from the biology of aging

by William B. Mair, Ines Alvarez-Garcia Aging affects us all, but we still do not know how the process evolves or if we can modulate its pace. This issue of PLO...

by William B. Mair, Ines Alvarez-Garcia Aging affects us all, but we still do not know how the process evolves or if we can modulate its pace. This issue of PLOS Biology presents a Collection of articles that explores different aspects of aging, discussing what challenges still need to be overcome. Aging affects us all, but we still do not know how the process evolves or if we can modulate its pace. This Editorial presents a Collection of articles that explores different aspects of aging, discussing what challenges still need to be overcome.